| 2025/0115,548 | COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Oct 14, 24 | Apr 10, 25 | Not available |
| 2025/0051,765 | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | Apr 29, 24 | Feb 13, 25 | Not available |
| 2025/0002,504 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | Jun 26, 24 | Jan 02, 25 | Not available |
| 2024/0384,251 | ENGINEERED AMYLASE VARIANTS | Jul 30, 24 | Nov 21, 24 | Not available |
| 2024/0360,226 | ANTIBODY MOLECULES AND CONJUGATES | Jun 25, 24 | Oct 31, 24 | Not available |
| 2024/0335,468 | TREATMENT OF RESPIRATORY CONDITIONS | Jul 08, 22 | Oct 10, 24 | Not available |
| 2024/0307,384 | PYRAZINE-CONTAINING COMPOUND | Mar 01, 24 | Sep 19, 24 | Not available |
| 2024/0269,165 | FINE SILICON PARTICLE-CONTAINING PREVENTIVE OR THERAPEUTIC AGENT FOR DISEASES | May 31, 22 | Aug 15, 24 | Osaka University |
| 2024/0261,366 | TREATMENT OF BETA-CELL FAILURE OR DYSFUNCTION | Jan 30, 24 | Aug 08, 24 | NOVMETAPHARMA CO., LTD.; Korea Advanced Institute of Science and Technology; |
| 2024/0261,447 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION | Jul 25, 22 | Aug 08, 24 | Not available |
| 2024/0226,089 | RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) INHIBITORS IN THE TREATMENT OF PANCREATIC DUCTAL CARCINOMA | Jan 10, 23 | Jul 11, 24 | Not available |
| 2024/0228,585 | FC-FUSION PROTEIN THERAPEUTIC FOR THE TREATMENT OF PANCREATITIS | May 02, 22 | Jul 11, 24 | Harvard University President and Fellows of Harvard College |
| 2024/0182,406 | COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Mar 14, 22 | Jun 06, 24 | Not available |
| 2024/0174,690 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | May 09, 23 | May 30, 24 | Not available |
| 2024/0150,423 | GLP-1 ANALOGUE-MODIFIED DIMERS WITH DIFFERENT CONFIGURATIONS, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN TREATMENT OF TYPE II DIABETES | Nov 09, 20 | May 09, 24 | Nanjing Finepeptide Biopharmaceutical Co.,Ltd |
| 2024/0139,337 | METHOD FOR TREATING A CANCER AND/OR CANCER METASTASIS | Nov 02, 22 | May 02, 24 | Not available |
| 2024/0041,980 | COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) | Aug 25, 23 | Feb 08, 24 | Not available |
| 2024/0026,326 | ENGINEERED AMYLASE VARIANTS | Sep 06, 23 | Jan 25, 24 | Not available |
| 2024/0009,163 | Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer | Jun 16, 23 | Jan 11, 24 | Ostentus Therapeutics, Inc. |
| 2023/0372,234 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles | Jul 13, 23 | Nov 23, 23 | Not available |